CASP3 and urinary bladder cancer: Liao et al. (2016) investigated the effect of EGCG on T24 bladder cancer cells and reported apoptosis via improved caspase 3/9, BAX expression, and regulated LC3B II, Beclin, and the PI3K/AKT pathway.